Safety and tolerability of cancer drugs studied in phase 3 randomized controlled trials (RCTs) over the last decade.
2018 ◽
Vol 36
(15_suppl)
◽
pp. 6588-6588
Keyword(s):
Phase 3
◽
2018 ◽
Vol 79
(2)
◽
pp. 287-293
◽
2018 ◽
Vol 32
(8)
◽
pp. 1305-1313
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. e13087-e13087